TransMedics Group, Inc. - Common Stock (TMDX)

Historical Holders from Q1 2019 to Q3 2025

Symbol: TMDX on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 33,940,151
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 37,127,253
Holdings value: $4,166,041,614
% of all portfolios: 0.005%
Number of holders: 384
Number of buys: 220
Number of sells: -170
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of TransMedics Group, Inc. - Common Stock (TMDX)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
FMR LLC	15%	+16.2%	$467,547,574	+$64,260,663	5,058,396	+15.9%	FMR LLC	31 Mar 2025
BlackRock, Inc.	14.6%		$664,054,661		4,955,262		BlackRock, Inc.	30 Jun 2025

Institutional Holders of TransMedics Group, Inc. - Common Stock (TMDX)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	37,127,253	$4,166,041,614	-$10,721,947	$104,788,112	$115,307,764	$112.2	384
2025 Q2	36,786,193	$4,927,662,357	-$289,195,543	$104,043,950	$158,508,385	$134.01	366
2025 Q1	39,009,472	$2,625,618,476	+$165,932,691	$46,493,564	$57,376,832	$67.28	295
2024 Q4	36,855,938	$2,297,784,694	-$388,696,786	$53,300,975	$41,663,088	$62.35	308
2024 Q3	36,492,550	$5,723,369,932	+$61,413,519	$44,884,860	$73,037,022	$157	365
2024 Q2	33,743,529	$5,082,407,329	+$90,020,373	$23,059,922	$59,901,574	$150.62	331
2024 Q1	34,019,976	$2,515,517,054	-$71,270,565	$27,306,482	$24,917,780	$73.94	251
2023 Q4	34,973,168	$2,760,564,347	-$4,091,949	$9,140,094	$13,544,388	$78.93	244
2023 Q3	34,944,103	$1,913,888,694	+$75,708,281	$9,165,150	$27,265,500	$54.75	218
2023 Q2	32,524,695	$2,731,143,204	+$226,755,585	$11,748,802	$8,322,418	$83.98	238
2023 Q1	29,891,511	$2,263,659,591	+$69,279,751	$15,267,168	$28,762,254	$75.73	221
2022 Q4	28,992,696	$1,789,417,886	+$38,499,424	$1,450,420	$16,084,232	$61.72	196
2022 Q3	28,283,349	$1,180,766,429	+$229,245,326	$13,565,000	$15,919,000	$41.74	174
2022 Q2	22,873,577	$719,448,960	+$66,828,071	$0	$1,995,000	$31.45	129
2022 Q1	20,846,434	$561,189,812	+$24,725,042	$434,000	$749,000	$26.94	107
2021 Q4	20,080,660	$384,713,814	+$27,430,654	$1,170,000	$1,004,000	$19.16	116
2021 Q3	19,228,003	$636,263,034	+$13,347,336	$3,578,000	$6,678,000	$33.09	116
2021 Q2	18,779,205	$623,049,047	+$1,144,101	$6,190,000	$8,848,000	$33.18	117
2021 Q1	18,628,828	$772,924,082	-$21,007,487	$12,863,000	$3,468,000	$41.49	104
2020 Q4	21,299,571	$423,671,614	-$4,482,122	$1,057,000		$19.9	67
2020 Q3	20,827,226	$287,000,555	+$6,185,866	$1,034,000		$13.78	71
2020 Q2	20,159,299	$361,233,740	+$92,950,873			$17.92	68
2020 Q1	15,072,652	$182,072,226	-$2,049,598			$12.08	53
2019 Q4	14,958,642	$284,357,755	-$13,693			$19.01	59
2019 Q3	14,301,117	$336,971,808	+$4,714,704			$23.75	49
2019 Q2	11,228,228	$311,861,739	+$311,859,996			$28.99	59
2019 Q1	54	$2,000				$37.04	1